245 related articles for article (PubMed ID: 24193321)
1. Augmentation of thrombin generation in neonates undergoing cardiopulmonary bypass.
Guzzetta NA; Szlam F; Kiser AS; Fernandez JD; Szlam AD; Leong T; Tanaka KA
Br J Anaesth; 2014 Feb; 112(2):319-27. PubMed ID: 24193321
[TBL] [Abstract][Full Text] [Related]
2. Optimizing Thrombin Generation with 4-Factor Prothrombin Complex Concentrates in Neonatal Plasma After Cardiopulmonary Bypass.
Franklin SW; Szlam F; Fernandez JD; Leong T; Tanaka KA; Guzzetta NA
Anesth Analg; 2016 Apr; 122(4):935-42. PubMed ID: 26599794
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the structural and mechanical effects of procoagulant agents on neonatal fibrin networks following cardiopulmonary bypass.
Nellenbach K; Guzzetta NA; Brown AC
J Thromb Haemost; 2018 Nov; 16(11):2159-2167. PubMed ID: 30182421
[TBL] [Abstract][Full Text] [Related]
4. Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypass.
Percy CL; Hartmann R; Jones RM; Balachandran S; Mehta D; Dockal M; Scheiflinger F; O'Donnell VB; Hall JE; Collins PW
Blood Coagul Fibrinolysis; 2015 Jun; 26(4):357-67. PubMed ID: 25928274
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis.
Martin AC; Le Bonniec B; Fischer AM; Marchand-Leroux C; Gaussem P; Samama CM; Godier A
Int J Cardiol; 2013 Oct; 168(4):4228-33. PubMed ID: 23928345
[TBL] [Abstract][Full Text] [Related]
6. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass.
Guzzetta NA; Huch S; Fernandez JD; Tosone SR; Miller BE
Paediatr Anaesth; 2009 Apr; 19(4):364-70. PubMed ID: 19143947
[TBL] [Abstract][Full Text] [Related]
7. Computational simulation and comparison of prothrombin complex concentrate dosing schemes for warfarin reversal in cardiac surgery.
Tanaka KA; Mazzeffi MA; Strauss ER; Szlam F; Guzzetta NA
J Anesth; 2016 Jun; 30(3):369-76. PubMed ID: 26749482
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Prothrombin Complex Concentrate with Activated Factor VII Use for Bleeding Following Cardiopulmonary Bypass in Children.
Benson JW; Hraska V; Scott JP; Stuth EAE; Yan K; Zhang J; Niebler RA
World J Pediatr Congenit Heart Surg; 2023 May; 14(3):282-288. PubMed ID: 36919404
[TBL] [Abstract][Full Text] [Related]
9. Prohemostatic Activity of Factor X in Combination With Activated Factor VII in Dilutional Coagulopathy.
Takeshita S; Ogawa S; Nakayama Y; Mukai N; Nakajima Y; Mizobe T; Sawa T; Tanaka KA
Anesth Analg; 2019 Aug; 129(2):339-345. PubMed ID: 30320649
[TBL] [Abstract][Full Text] [Related]
10. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model.
Dickneite G; Dörr B; Kaspereit F; Tanaka KA
J Trauma; 2010 May; 68(5):1151-7. PubMed ID: 19996804
[TBL] [Abstract][Full Text] [Related]
11. Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products.
Tang M; Fenger-Eriksen C; Wierup P; Greisen J; Ingerslev J; Hjortdal V; Sørensen B
Thromb Res; 2017 Jun; 154():73-79. PubMed ID: 28437748
[TBL] [Abstract][Full Text] [Related]
12. A Comparison of Prothrombin Complex Concentrate and Recombinant Activated Factor VII for the Management of Bleeding With Cardiac Surgery.
Katz A; Ahuja T; Arnouk S; Lewis TC; Marsh K; Papadopoulos J; Merchan C
J Intensive Care Med; 2022 Feb; 37(2):231-239. PubMed ID: 33402016
[TBL] [Abstract][Full Text] [Related]
13. Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro.
Perzborn E; Heitmeier S; Laux V; Buchmüller A
Thromb Res; 2014 Apr; 133(4):671-81. PubMed ID: 24529498
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model.
Godier A; Miclot A; Le Bonniec B; Durand M; Fischer AM; Emmerich J; Marchand-Leroux C; Lecompte T; Samama CM
Anesthesiology; 2012 Jan; 116(1):94-102. PubMed ID: 22042412
[TBL] [Abstract][Full Text] [Related]
15. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P).
Tanaka KA; Taketomi T; Szlam F; Calatzis A; Levy JH
Anesth Analg; 2008 Mar; 106(3):732-8, table of contents. PubMed ID: 18292410
[TBL] [Abstract][Full Text] [Related]
16. A Step Toward Balance: Thrombin Generation Improvement via Procoagulant Factor and Antithrombin Supplementation.
Mitrophanov AY; Szlam F; Sniecinski RM; Levy JH; Reifman J
Anesth Analg; 2016 Sep; 123(3):535-46. PubMed ID: 27541717
[TBL] [Abstract][Full Text] [Related]
17. Levels of prothrombin activation peptide F1+2 in patients with a bleeding tendency.
Ingerslev J; Holm M; Christiansen K; Knudsen L; Négrier C
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S129-34. PubMed ID: 9819044
[TBL] [Abstract][Full Text] [Related]
18. Recombinant activated factor VII and prothrombin complex concentrates have different effects on bleeding and arterial thrombosis in the haemodiluted rabbit.
Le Saché F; Le Bonniec B; Gaussem P; Dizier B; Tagzirt M; Godier A; Emmerich J; Samama CM
Br J Anaesth; 2012 Apr; 108(4):586-93. PubMed ID: 22258204
[TBL] [Abstract][Full Text] [Related]
19. Activated Factor 7 Versus 4-Factor Prothrombin Complex Concentrate for Critical Bleeding Post-Cardiac Surgery.
Mehringer SL; Klick Z; Bain J; McNeely EB; Subramanian S; Pass LJ; Drinkwater D; Reddy VS
Ann Pharmacother; 2018 Jun; 52(6):533-537. PubMed ID: 29332420
[TBL] [Abstract][Full Text] [Related]
20. Prothrombin complex concentrate mitigates diffuse bleeding after cardiopulmonary bypass in a porcine model.
Kaspereit F; Hoffmann S; Pragst I; Dickneite G
Br J Anaesth; 2010 Nov; 105(5):576-82. PubMed ID: 20716565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
